Health Outcomes Sciences
HOS personalizes predictive analytics and evidence at the point of care, helping physicians reduce variance and improve outcomes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | $1.0m | Debt | |
| Total Funding | 000k | ||
Related Content
Health Outcomes Sciences (HOS) operates as a specialized developer of predictive analytics and clinical decision support software for the healthcare sector. The company was founded in 2010 by Dr. John Spertus, a cardiologist and professor at the University of Missouri-Kansas City. Dr. Spertus's extensive research in assessing patient health outcomes, measuring healthcare quality, and using IT to guide medical decisions formed the foundation of the company. His work includes the development of widely used assessment tools like the Seattle Angina Questionnaire (SAQ) and the Kansas City Cardiomyopathy Questionnaire (KCCQ).
The core of HOS's offering is the ePRISM™ platform, a patented content enablement system that translates scientific, evidence-based models into automated decision-support solutions at the point of care. Rather than relying on generalized population data, ePRISM provides physicians with predictive insights tailored to each patient's specific procedural risks by analyzing their unique disease severity, co-morbidities, and demographic profile. This enables healthcare providers to customize the intensity of treatment, aiming to improve patient outcomes, reduce care variability, and lower healthcare costs. The company serves healthcare organizations, life science partners, and health systems by providing the necessary data to enhance clinical, patient, and financial results. The business model centers on deploying this platform to help organizations optimize decision-making and resource consumption.
A significant milestone in the company's history occurred in February 2021, when Terumo Corporation, a global medical technology leader, acquired all assets of Health Outcomes Sciences. This acquisition was a strategic move for Terumo to expand its presence in the digital healthcare market. Following the acquisition, the ePRISM platform was integrated into Terumo Business Edge, a unit focused on providing solutions to healthcare systems to reduce care variation and improve quality metrics. Prior to the acquisition, HOS had been venture-backed, securing funding from investors such as Grayhawk Capital and Kansas Bioscience Authority. Keywords: Health Outcomes Sciences, ePRISM, Terumo, John Spertus, clinical decision support, predictive analytics, precision medicine, healthcare analytics, patient outcomes, risk prediction models, cardiovascular outcomes, evidence-based medicine, point of care technology, healthcare data, personalized medicine, Kansas City Cardiomyopathy Questionnaire, Seattle Angina Questionnaire, care variation reduction, medical technology, health outcomes research